All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Fulgent Genetics, Inc. revenue reports

Fulgent Genetics, Inc. financial reports, Fulgent Genetics, Inc. annual revenue in 2024. When does Fulgent Genetics, Inc. report revenue?
Add to widgets
Added to widgets

Fulgent Genetics, Inc. total revenue, net income and dynamics of changes in US dollar today

Fulgent Genetics, Inc. net revenue for today is 359 429 000 $. Fulgent Genetics, Inc. net income is now 200 691 000 $. These are the main financial indicators of Fulgent Genetics, Inc.. Fulgent Genetics, Inc. financial report on the graph shows the dynamics of assets. Fulgent Genetics, Inc. net income is shown in blue on the graph. All information on Fulgent Genetics, Inc. total revenue on this chart is created in the form of yellow bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 359 429 000 $ +6 593.280 % ↑ 200 691 000 $ -
31/12/2020 294 978 000 $ +5 099.680 % ↑ 166 307 000 $ -
30/09/2020 101 716 000 $ +883.05 % ↑ 46 638 000 $ +3 090.010 % ↑
30/06/2020 17 265 000 $ +104.95 % ↑ 3 321 000 $ +903.32 % ↑
30/09/2019 10 347 000 $ - 1 462 000 $ -
30/06/2019 8 424 000 $ - 331 000 $ -
31/03/2019 5 370 000 $ - -1 908 000 $ -
31/12/2018 5 673 000 $ - -2 053 000 $ -
Show:
to

Fulgent Genetics, Inc. financial report charts

The dates of the latest financial statements of Fulgent Genetics, Inc.: 31/12/2018, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The current date of the financial report of Fulgent Genetics, Inc. for today is 31/03/2021. Gross profit Fulgent Genetics, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Fulgent Genetics, Inc. is 285 354 000 $

Fulgent Genetics, Inc. quarterly report dates

Cost of revenue Fulgent Genetics, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Fulgent Genetics, Inc. is 74 075 000 $ Total revenue Fulgent Genetics, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Fulgent Genetics, Inc. is 359 429 000 $ Operating income Fulgent Genetics, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Fulgent Genetics, Inc. is 266 922 000 $

Net income Fulgent Genetics, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Fulgent Genetics, Inc. is 200 691 000 $ Current assets Fulgent Genetics, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Fulgent Genetics, Inc. is 659 140 000 $ Total assets Fulgent Genetics, Inc. refers to the total amount of assets owned by a person or entity. Total assets Fulgent Genetics, Inc. is 999 083 000 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
285 354 000 $ 243 206 000 $ 75 455 000 $ 9 548 000 $ 6 462 000 $ 4 804 000 $ 2 402 000 $ 2 904 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
74 075 000 $ 51 772 000 $ 26 261 000 $ 7 717 000 $ 3 885 000 $ 3 620 000 $ 2 968 000 $ 2 769 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
359 429 000 $ 294 978 000 $ 101 716 000 $ 17 265 000 $ 10 347 000 $ 8 424 000 $ 5 370 000 $ 5 673 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - 10 347 000 $ 8 424 000 $ 5 370 000 $ 5 673 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
266 922 000 $ 231 167 000 $ 63 523 000 $ 2 640 000 $ 1 509 000 $ 295 000 $ -1 823 000 $ -1 029 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
200 691 000 $ 166 307 000 $ 46 638 000 $ 3 321 000 $ 1 462 000 $ 331 000 $ -1 908 000 $ -2 053 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
5 422 000 $ 3 818 000 $ 3 177 000 $ 1 849 000 $ 1 744 000 $ 1 574 000 $ 1 424 000 $ 1 426 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
92 507 000 $ 63 811 000 $ 38 193 000 $ 14 625 000 $ 8 838 000 $ 8 129 000 $ 7 193 000 $ 6 702 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
659 140 000 $ 523 616 000 $ 195 615 000 $ 41 183 000 $ 39 205 000 $ 34 795 000 $ 36 301 000 $ 39 543 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
999 083 000 $ 700 461 000 $ 247 311 000 $ 95 915 000 $ 61 145 000 $ 56 436 000 $ 55 652 000 $ 53 904 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
151 461 000 $ 87 426 000 $ 53 031 000 $ 2 431 000 $ 20 522 000 $ 9 165 000 $ 5 288 000 $ 6 736 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 4 253 000 $ 2 909 000 $ 3 203 000 $ 2 738 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 6 619 000 $ 5 294 000 $ 5 691 000 $ 2 752 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 10.83 % 9.38 % 10.23 % 5.11 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
801 566 000 $ 569 387 000 $ 186 955 000 $ 87 043 000 $ 54 526 000 $ 51 142 000 $ 49 961 000 $ 51 152 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 3 903 000 $ 675 000 $ 1 055 000 $ 778 000 $

Last revenue report of Fulgent Genetics, Inc. was 31/03/2021. According to last financial report total revenue in Fulgent Genetics, Inc. was 359 429 000 US dollar and changed by +6 593.280% since last year. Net income in Fulgent Genetics, Inc. was 200 691 000 $ in last quartal, net income changes to +3 090.010%.

Current cash Fulgent Genetics, Inc. - the sum of all of the cash a company has on the date of report. Current cash Fulgent Genetics, Inc. is 151 461 000 $

Fulgent Genetics, Inc. stocks data

Fulgent Genetics, Inc. financials